{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:13:37Z","timestamp":1768594417439,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"DOI":"10.1007\/s00240-025-01930-x","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:04:06Z","timestamp":1768550646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features of hypocitraturic kidney stone formers: an observational and retrospective real-life study in an Italian kidney stone center"],"prefix":"10.1007","volume":"54","author":[{"given":"Matteo Brambilla","family":"Pisoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia Edvige","family":"Foligno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Giamb\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-4600","authenticated-orcid":false,"given":"Marco","family":"Simonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4481-5693","authenticated-orcid":false,"given":"Giuseppe","family":"Vezzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"1930_CR1","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3390\/nu11112576","volume":"11","author":"D Granchi","year":"2019","unstructured":"Granchi D, Baldini N, Ulivieri FM, Caudarella R (2019) Role of citrate in pathophysiology and medical management of bone diseases. Nutrients 11:2576. https:\/\/doi.org\/10.3390\/nu11112576","journal-title":"Nutrients"},{"key":"1930_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ki.1990.265","volume":"38","author":"LL Hamm","year":"1990","unstructured":"Hamm LL (1990) Renal handling of citrate. Kidney Int 38:728\u2013735. https:\/\/doi.org\/10.1038\/ki.1990.265","journal-title":"Kidney Int"},{"key":"1930_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jcrysgro.2007.04.053","volume":"306","author":"ML Weaver","year":"2007","unstructured":"Weaver ML, Qui RS, Hoyer JR, Casey WH, Nancollas GH, DeYoreo J (2007) Inhibition of calcium oxalate monohydrate growth by citrate and the effect of the background electrolyte. J Cryst Growth 306:135\u2013145. https:\/\/doi.org\/10.1016\/j.jcrysgro.2007.04.053","journal-title":"J Cryst Growth"},{"key":"1930_CR4","doi-asserted-by":"publisher","first-page":"22425","DOI":"10.1073\/pnas.1009219107","volume":"107","author":"YY Hu","year":"2010","unstructured":"Hu YY, Rawal A, Schmidt-Rohr K (2010) Strongly bound citrate stabilizes the apatite nanocrystals in bone. Proc Natl Acad Sci USA 107:22425\u201322429. https:\/\/doi.org\/10.1073\/pnas.1009219107","journal-title":"Proc Natl Acad Sci USA"},{"key":"1930_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0022-5347(17)70173-5","volume":"53","author":"E Shorr","year":"1945","unstructured":"Shorr E (1945) The possible usefulness of estrogens and aluminum hydroxide gels in the management of renal stone. J Urol 53:507\u2013520. https:\/\/doi.org\/10.1016\/S0022-5347(17)70173-5","journal-title":"J Urol"},{"key":"1930_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0022-5347(17)70436-3","volume":"50","author":"WW Scott","year":"1943","unstructured":"Scott WW, Huggins C, Selman BC (1943) Metabolism of citric acid in urolithiasis. J Urol 50:202\u2013211. https:\/\/doi.org\/10.1016\/S0022-5347(17)70436-3","journal-title":"J Urol"},{"key":"1930_CR7","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.juro.2012.11.107","volume":"189","author":"MG Penido","year":"2013","unstructured":"Penido MG, Srivastava T, Alon US (2013) Pediatric primary urolithiasis: 12-year experience at a midwestern children\u2019s hospital. J Urol 189:1493\u20131497. https:\/\/doi.org\/10.1016\/j.juro.2012.11.107","journal-title":"J Urol"},{"key":"1930_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000070134","volume":"70","author":"A Tefekli","year":"2003","unstructured":"Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M (2003) Metabolic risk factors in pediatric and adult calcium oxalate stone formers: is there any differences? Urol Int 70:273\u2013277. https:\/\/doi.org\/10.1159\/000070134","journal-title":"Urol Int"},{"key":"1930_CR9","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.100193","volume":"1","author":"A Emami-Naini","year":"2012","unstructured":"Emami-Naini A, Eshraghi A, Shahidi S, Mortazavi M, Seyrafian S, Roomizadeh P, Abtahi SH, Ghafoori HB (2012) Metabolic evaluation in patients with nephrolithiasis: a report from Isfahan, Iran. Adv Biomed Res 1:65. https:\/\/doi.org\/10.4103\/2277-9175.100193","journal-title":"Adv Biomed Res"},{"key":"1930_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/978-1-4684-7272-1_77","volume":"106","author":"DH Hosking","year":"1985","unstructured":"Hosking DH, Wilson JW, Liedtke RR, Smith LH, Wilson DM (1985) Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis. J Lab Clin Med 106:682\u2013689. https:\/\/doi.org\/10.1007\/978-1-4684-7272-1_77","journal-title":"J Lab Clin Med"},{"key":"1930_CR11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/ndt\/9.6.642","volume":"9","author":"B Hess","year":"1994","unstructured":"Hess B, Michel R, Takkinen R, Jaeger P (1994) Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list. Nephrol Dial Transpla 9:642\u2013649. https:\/\/doi.org\/10.1093\/ndt\/9.6.642","journal-title":"Nephrol Dial Transpla"},{"key":"1930_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/jbmr.5650080703","volume":"8","author":"K Sakhaee","year":"1993","unstructured":"Sakhaee K, Williams RH, Oh MS, Padalino P, Adams-Huet B, Whitson IP, Pak CYC (1993) Alkali absorption and citrate excretion in calcium nephrolithiasis. J Bone Miner Res 8:789\u2013794. https:\/\/doi.org\/10.1002\/jbmr.5650080703","journal-title":"J Bone Miner Res"},{"key":"1930_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00756-5","volume":"8","author":"E Ruiz-Agudo","year":"2017","unstructured":"Ruiz-Agudo E, Burgos-Cara A, Ruiz-Agudo C, Iba\u00f1ez-Velasco A, C\u00f6lfen H, Rodriguez-Navarro C (2017) A non-classical view on calcium oxalate precipitation and the role of citrate. Nat Commun 8:768. https:\/\/doi.org\/10.1038\/s41467-017-00756-5","journal-title":"Nat Commun"},{"key":"1930_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00240-015-0819-8","volume":"44","author":"Y Song","year":"2016","unstructured":"Song Y, Hernandez N, Shoag J, Goldfarb DS, Eisner BH (2016) Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis. Urolithiasis 44:145\u2013148. https:\/\/doi.org\/10.1007\/s00240-015-0819-8","journal-title":"Urolithiasis"},{"key":"1930_CR15","doi-asserted-by":"publisher","first-page":"849e853","DOI":"10.1016\/j.amjcard.2016.06.041","volume":"118","author":"W Vongpatanasin","year":"2016","unstructured":"Vongpatanasin W, Peri-Okonny P, Velasco A, Arbique D, Wang Z, Ravikumar P, Adams-Huet B, Moe OW, Pak CYC (2016) Effects of potassium magnesium citrate supplementation on 24-hour ambulatory blood pressure and oxidative stress marker in prehypertensive and hypertensive subjects. Am J Cardiol 118:849e853. https:\/\/doi.org\/10.1016\/j.amjcard.2016.06.041","journal-title":"Am J Cardiol"},{"key":"1930_CR16","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/s0022-5347(01)68155-2","volume":"158","author":"B Ettinger","year":"1997","unstructured":"Ettinger B, Pak CY, Citron JT, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069\u20132073. https:\/\/doi.org\/10.1016\/s0022-5347(01)68155-2","journal-title":"J Urol"},{"key":"1930_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0022-5347(17)46962-x","volume":"134","author":"CY Pak","year":"1985","unstructured":"Pak CY, Fuller C, Sakhaee K, Preminger GM, Britton F (1985) Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 134:11\u201319. https:\/\/doi.org\/10.1016\/s0022-5347(17)46962-x","journal-title":"J Urol"},{"key":"1930_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-022-01387-2","volume":"51","author":"G Zeng","year":"2023","unstructured":"Zeng G, Zhu W et al (2023) International alliance of urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis. Urolithiasis 51:4. https:\/\/doi.org\/10.1007\/s00240-022-01387-2","journal-title":"Urolithiasis"},{"key":"1930_CR19","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1001\/jama.2020.0662","volume":"323","author":"AD Rule","year":"2020","unstructured":"Rule AD, Lieske JC, Pais VM (2020) Management of kidney stones in 2020. JAMA 323:1961\u20131962. https:\/\/doi.org\/10.1001\/jama.2020.0662","journal-title":"JAMA"},{"key":"1930_CR20","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/ndt\/gfp760","volume":"25","author":"G Vezzoli","year":"2010","unstructured":"Vezzoli G, Terranegra A, Arcidiacono T, Gambaro G, Milanesi L, Mosca E, Soldati L (2010) Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region. Nephrol Dial Transplant 25:2245\u20132252. https:\/\/doi.org\/10.1093\/ndt\/gfp760","journal-title":"Nephrol Dial Transplant"},{"key":"1930_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/ckj\/sfz098","volume":"13","author":"A Wiegand","year":"2020","unstructured":"Wiegand A, Fischer G, Seeger H, Fuster D, Dhayat N, Bonny O, Ernandez T, Kim MJ, Wagner CA, Mohebbi N (2020) Impact of potassium citrate on urinary risk profile, glucose and lipid metabolism of kidney stone formers in Switzerland. Clin Kidney J 13:1037\u20131048. https:\/\/doi.org\/10.1093\/ckj\/sfz098","journal-title":"Clin Kidney J"},{"key":"1930_CR22","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.numecd.2015.03.005","volume":"25","author":"G Vezzoli","year":"2015","unstructured":"Vezzoli G, Dogliotti E et al (2015) Dietary style and acid load in an Italian population of calcium kidney stone formers. Nutr Metab Cardiovasc Dis 25:588\u2013593. https:\/\/doi.org\/10.1016\/j.numecd.2015.03.005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1930_CR23","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2215\/CJN.02620409","volume":"20","author":"EN Taylor","year":"2009","unstructured":"Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20:2253\u20132259. https:\/\/doi.org\/10.2215\/CJN.02620409","journal-title":"J Am Soc Nephrol"},{"key":"1930_CR24","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1681\/ASN.2007091038","volume":"19","author":"O Bonny","year":"2008","unstructured":"Bonny O, Rubin A, Huang CL, Frawley WH, Pak CYC, Moe OW (2008) Mechanism of urinary cal cium regulation by urinary magnesium and pH. J Am Soc Nephrol 19:1530\u20131537. https:\/\/doi.org\/10.1681\/ASN.2007091038","journal-title":"J Am Soc Nephrol"},{"key":"1930_CR25","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.juro.2011.12.077","volume":"187","author":"MD Sorensen","year":"2012","unstructured":"Sorensen MD, Kahn AJ et al (2012) Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol 187:1645\u20131650. https:\/\/doi.org\/10.1016\/j.juro.2011.12.077","journal-title":"J Urol"},{"key":"1930_CR26","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14943","volume":"9","author":"ML Prochaska","year":"2021","unstructured":"Prochaska ML, Moe OW, Asplin JR, Coe FL, Worcester EM (2021) Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers. Physiol Rep 9:e14943. https:\/\/doi.org\/10.14814\/phy2.14943","journal-title":"Physiol Rep"},{"key":"1930_CR27","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1681\/ASN.2013010080","volume":"24","author":"E Ohana","year":"2013","unstructured":"Ohana E, Shcheynikov N, Moe OW, Muallem S (2013) SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis. J Am Soc Nephrol 24:1617\u20131626. https:\/\/doi.org\/10.1681\/ASN.2013010080","journal-title":"J Am Soc Nephrol"},{"key":"1930_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00240-018-1035-0","volume":"46","author":"RW Walker","year":"2018","unstructured":"Walker RW, Zhang S, Coleman-Barnett JA, Lee Hamm L, Hering-Smith KS (2018) Calcium receptor signaling and citrate transport. Urolithiasis 46:409\u2013418. https:\/\/doi.org\/10.1007\/s00240-018-1035-0","journal-title":"Urolithiasis"},{"key":"1930_CR29","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1089\/end.2017.0210","volume":"31","author":"HW Kang","year":"2017","unstructured":"Kang HW, Seo SP, Kim WT, Kim YJ, Yun SJ, Kim WJ, Lee SC (2017) Metabolic characteristics and risks associated with stone recurrence in Korean young adult stone patients. J Endourol 31:806\u2013811. https:\/\/doi.org\/10.1089\/end.2017.0210","journal-title":"J Endourol"},{"key":"1930_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2215\/CJN.0000000000000428","volume":"19","author":"K Arivoli","year":"2024","unstructured":"Arivoli K, Valicevic AN, Oerline MK, Hsi RS, Patel SR, Hollingsworth JM, Shahinian VB (2024) Preventive pharmacological therapy and risk of recurrent urinary stone disease. Clin J Am Soc Nephrol 19:565\u2013572. https:\/\/doi.org\/10.2215\/CJN.0000000000000428","journal-title":"Clin J Am Soc Nephrol"},{"key":"1930_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/j.ajkd.2024.02.010.","volume":"84","author":"PM Ferraro","year":"2024","unstructured":"Ferraro PM, Taylor EN, Curhan GC (2024) 24-hour urinary chemistries and kidney stone risk. Am J Kidney Dis 84:164\u2013169. https:\/\/doi.org\/10.1053\/j.ajkd.2024.02.010.","journal-title":"Am J Kidney Dis"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-025-01930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00240-025-01930-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-025-01930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:04:07Z","timestamp":1768550647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00240-025-01930-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1930"],"URL":"https:\/\/doi.org\/10.1007\/s00240-025-01930-x","relation":{},"ISSN":["2194-7236"],"issn-type":[{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"33"}}